Digital therapeutics company Big Health has been granted FDA 510(k) clearance for its SleepioRx digital therapeutic aimed at reducing insomnia and improving sleep.
The 90-day SleepioRX digital treatment addresses insomnia disorder through evidence-based strategies focusing on the cognitive and behavioral aspects causing insomnia and long-term sleep issues.
The company touts that its use of...
Digital therapeutics company Big Health announced it acquired Limbix, a maker of prescription digital therapeutics aimed at treating depression in teens and young adults.
Limbix is the creator of SparkRx, a PDTx that uses the principles of cognitive behavioral therapy to address depression in teens and young adults ages 13 to 22.
The self-guided CBT-based treatment was released in October 2021...
Evernorth, the health services arm of insurer Cigna, announced it has added five new programs to its digital health formulary, including offerings from Big Health and Quit Genius.
The new additions to the formulary are Big Health's Sleepio digital therapeutic for insomnia and its Daylight tool for anxiety, Quit Genius' alcohol use disorder and opioid use disorder programs, and HealthBeacon's...
In early February, Big Health announced Gabriela Perez had joined the digital therapeutics company as chief commercial officer. She most recently worked at the reproductive care-focused Ovia Health, which was acquired by Labcorp in August last year.
Perez sat down with MobiHealthNews to discuss her new job, what she's learned from past roles and how the digital therapeutics space might evolve....
Parallel Learning, a digital health startup focused on diagnosing, treating and supporting children with learning differences, announced two new hires to its executive team.
Susan Liu, previously vice president of clinical operations at digital mental health company Cerebral, joins the startup as chief operating officer.
"I'm thrilled to join the Parallel team and to dedicate my focus to...
Wheel, a virtual care staffing and services vendor, raised $150 million in a Series C funding round led by Lightspeed Venture Partners and Tiger Global.
Other investors participating in the round include Coatue, Salesforce Ventures, CRV, Tusk Venture Partners and Silverton Partners. The Series C comes less than a year after a $50 million round from May, and brings the company's total raise to $...
Digital therapeutics are a growing field in the larger digital health space, but they’re still relatively new. What’s the state of the market, and how can the companies behind these products encourage their uptake?
With regard to mental and behavioral health – a clinical area that’s ripe for digital health investment – many people who have mental illnesses don’t receive care. The scalability of...
Sometimes legends walk among us. We would be wise to pay attention.
Dr. Aaron Beck, regarded as the father of modern cognitive behavioral therapy (CBT), passed away last month, soon after celebrating his 100th birthday. Dr. Beck’s historic life compels us to examine his pioneering work in furthering behavioral medicine and the need to extend that work to the current state of mental health...
Adults in Scotland can now access Big Health’s digital therapeutics for anxiety and insomnia for free via the NHS.
People across all 14 NHS Scotland health board areas are able to self-refer or visit their GP to receive cognitive behavioural therapy (CBT) through the Daylight and Sleepio apps.
In October last year, the Scottish Government made the Big Health apps available across five NHS...
Using Sleepio, a digital therapeutic to reduce insomnia, improved sleep, anxiety and depression more than other psychological interventions alone, according to a study published in Behaviour Research and Therapy.
The study was partially funded by Big Health, Sleepio’s parent company, and most authors were Big Health employees or paid consultants.
TOP-LINE DATA
Patients who used Sleepio achieved...
